Muhib Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhib Khan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Rushna Ali
2 shared publications- Anna Liu
Department of Neurology, Mayo Clinic Rochester, 200 First St. SW, Rochester, MN 55905, USA
1 shared publication Ashok Sriram
Michigan State University, United States
1 shared publicationDmitry Do Esterov
1 shared publicationEmily Ruether
Michigan State University, United States
1 shared publicationHayden Boyce
Michigan State University, United States
1 shared publication
Latest Publications
- 2 April 2026
- Published by Wolters Kluwer Health in Contemporary Neurosurgery
- Vol. 48 (4) , 1-7
Noninvasive Neuromodulation to Enhance Neurological Function and Recovery
Noninvasive brain stimulation (NIBS) techniques, including transcranial magnetic stimulation (TMS), transcranial direct and alternating current stimulation (tDCS, tACS), and transcutaneous vagus nerve stimulation (tVNS), represent promising tools for neurorehabilitation and symptom management across neurological and psychiatric conditions. These modalities modulate cortical excitability, foster neuroplasticity, and target maladaptive network activity. Evidence supports applications in stroke, Parkinson disease (PD), Alzheimer disease, chronic pain, and psychiatric disorders, though methodological variability, heterogeneous patient populations, and lack of standardization limit clinical translation. This review synthesizes current knowledge, highlights therapeutic potential, and underscores the need for rigorous trials to establish efficacy and optimize treatment protocols.
- 2 April 2026
- Published by Wolters Kluwer Health in Contemporary Neurosurgery
- Vol. 48 (4) , 1-7
Noninvasive Neuromodulation to Enhance Neurological Function and Recovery
Noninvasive brain stimulation (NIBS) techniques, including transcranial magnetic stimulation (TMS), transcranial direct and alternating current stimulation (tDCS, tACS), and transcutaneous vagus nerve stimulation (tVNS), represent promising tools for neurorehabilitation and symptom management across neurological and psychiatric conditions. These modalities modulate cortical excitability, foster neuroplasticity, and target maladaptive network activity. Evidence supports applications in stroke, Parkinson disease (PD), Alzheimer disease, chronic pain, and psychiatric disorders, though methodological variability, heterogeneous patient populations, and lack of standardization limit clinical translation. This review synthesizes current knowledge, highlights therapeutic potential, and underscores the need for rigorous trials to establish efficacy and optimize treatment protocols.
- Open Access
Cervical Artery Dissection in Autosomal Dominant Polycystic Kidney Disease
Background and Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by multisystem involvement, including renal cysts, hepatic cysts, intracranial aneurysms, and aortic root dilatation and dissection. Though exceedingly rare, cervical artery dissections (CeAD) have been reported in association with ADPKD. The aim of this retrospective observational study is to investigate clinical features in patients with ADPKD that increase the probability of an associated CeAD diagnosis. Materials and Methods: The National Inpatient Sample from 2016 to 2020 was utilized to compare clinical features for patients with an ICD-10 code diagnosis of ADPKD, CeAD, and both ADPKD and CeAD. The Cochran–Armitage test and Chi-square test were utilized to assess clinical features or trends in ADPKD patients associated with a concurrent CeAD diagnosis. Results: Between 2016 and 2020, there were 224,065 people with ADPKD, 86,135 with CeAD and 155 with both (0.05%). The total cohort had a mean age of 56.74 years, with 47.26% female participants (p = 0.70), and was predominantly white (66.15%, p < 0.001). In patients with ADPKD, comorbid acute ischemic stroke (p < 0.001), transient ischemic attack (p < 0.001), aortic dissection (p < 0.001), coronary artery dissection (p < 0.001), subarachnoid hemorrhage (p < 0.001), coagulation defects (p = 0.002), and hypertension (p < 0.001) are risk factors associated with an increased probability of concomitant CeAD. Conclusions: CeAD in ADPKD patients is rare. In ADPKD patients, acute ischemic stroke, transient ischemic attack, aortic dissection, coronary artery dissection, subarachnoid hemorrhage, coagulation defects, and hypertension are risk factors of concomitant CeAD. Recognizing these factors can aid in the decision to screen for concomitant CeAD in patients with ADPKD.
Open AccessCervical Artery Dissection in Autosomal Dominant Polycystic Kidney Disease
Background and Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by multisystem involvement, including renal cysts, hepatic cysts, intracranial aneurysms, and aortic root dilatation and dissection. Though exceedingly rare, cervical artery dissections (CeAD) have been reported in association with ADPKD. The aim of this retrospective observational study is to investigate clinical features in patients with ADPKD that increase the probability of an associated CeAD diagnosis. Materials and Methods: The National Inpatient Sample from 2016 to 2020 was utilized to compare clinical features for patients with an ICD-10 code diagnosis of ADPKD, CeAD, and both ADPKD and CeAD. The Cochran–Armitage test and Chi-square test were utilized to assess clinical features or trends in ADPKD patients associated with a concurrent CeAD diagnosis. Results: Between 2016 and 2020, there were 224,065 people with ADPKD, 86,135 with CeAD and 155 with both (0.05%). The total cohort had a mean age of 56.74 years, with 47.26% female participants (p = 0.70), and was predominantly white (66.15%, p < 0.001). In patients with ADPKD, comorbid acute ischemic stroke (p < 0.001), transient ischemic attack (p < 0.001), aortic dissection (p < 0.001), coronary artery dissection (p < 0.001), subarachnoid hemorrhage (p < 0.001), coagulation defects (p = 0.002), and hypertension (p < 0.001) are risk factors associated with an increased probability of concomitant CeAD. Conclusions: CeAD in ADPKD patients is rare. In ADPKD patients, acute ischemic stroke, transient ischemic attack, aortic dissection, coronary artery dissection, subarachnoid hemorrhage, coagulation defects, and hypertension are risk factors of concomitant CeAD. Recognizing these factors can aid in the decision to screen for concomitant CeAD in patients with ADPKD.
- Open Access
- 12 May 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 12, 100348
Leukoaraiosis does not impact motor outcomes in Parkinson’s patients post deep brain stimulation
- 12 May 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 12, 100348
Open AccessLeukoaraiosis does not impact motor outcomes in Parkinson’s patients post deep brain stimulation